Clinical trial · Interventional
Patency and Safety of the Drug Eluting Covered Biliary Stent Comparing to the Common Covered Biliary Stent
Clinical Trial Comparing Patency and Safety of the Paclitaxel Eluting Covered Metallic Biliary Stent(Niti-S Mira-Cover Biliary Stent ) to the Common Covered Metallic Biliary Stent(Niti-S Biliary Stent)
NCT01512563CI-TRIAL-00043956MIRA-covercompletedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Paclitaxel covered metal biliary stent extents their patency rate comparing to the Common Covered Metallic Biliary Stent.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Biliary Stricture | — | UNRESOLVED | — |
| Malignant Neoplasms | Malignant Neoplasm | ONTOLOGY_EXACT | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Biliary stent | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Paclitaxel ElutingCovered Metal Stent
- interventionNames
- Device: Biliary stent
- type
- ACTIVE_COMPARATOR
- label
- Covered Metal Stent
- interventionNames
- Device: Biliary stent
Primary outcomes (1)
- measure
- Accumulative Patency Rate
- timeFrame
- 6 month
Secondary outcomes (3)
- measure
- Accumulative Survival Rate
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 19 Years
- Maximum age
- 90 Years
Show eligibility criteria text
Inclusion Criteria: * Patient who is inoperable and/or unresectable cases of pancreatic cancer and/or biliary cancer with mid or distal CBD invasion * Among patient of a.,Patient who previously had surgical biliary drainage of plastic stent have eligibility Exclusion Criteria: * Patient who have life expectancy under 3 months * Patient who have severe metastasis of Liver or whole body * Patient who previously had surgical biliary drainage
References
Publications (0)
Data not yet available
No reference posted for this study.